SIRS 2018 - Florence | Progress In Mind

Home

Progress in Mind reports from The 6th Biennial Schizophrenia International Research Society Conference (SIRS)

Once again, the Progress in Mind Resource Center is pleased to bring you highlights from the SIRS Conference in Florence, Italy held from 4-8 April 2018. We strive to capture and bring you some of the latest research around schizophrenia as reported from this exciting Conference.

Stay tuned as we bring you the latest from SIRS 2018!

Read time: 3 min

Schizophrenia and identifying those at high risk – the LJ Seidman memorial lecture

Tribute was paid to the late Larry Seidman during a memorial lecture highlighting his and ongoing...

Read time: 5 min

"OPTiMiSE”ing treatment of first-episode schizophrenia

Despite the availability of effective antipsychotic medications for decades, significant numbers of...

Read time: 4 min

Glutamate synaptic deficits are likely early targets for prevention of schizophrenia

Computational neurosciences can form a bridge between the outcomes of pure research and clinical...

Read time: 3 min

Schizophrenia in the near future

Professor William Carpenter, Maryland, USA, gave an insightful presentation during SIRS 2018 in...

Read time: 2 min

Antipsychotic treatment response worsens in relapses following response in first episode schizophrenia

Treatment-resistant schizophrenia (TRS) is increasingly being recognized as a focus area in...

Read time: 6 min

SMART works in psychosis

Smart applications that use mobile devices and computers to track symptoms and facilitate treatment...

Read time: 5 min

Congress highlights

Psychotic disorders – from dawn ‘til dusk

‘From dusk ‘til dawn’ was the title of a symposium at SIRS 2018 that brought...

Read time: 3 min

Congress highlights

Investing in recovery – translating intervention into action

Worldwide, recovery - defined by the presenter David McDaid, London, UK as the ability of affected...

Read time: 4 min

Congress highlights

Does biology read the DSM?

This was the provocative title of a symposium that took place during this year’s SIRS...

Read time: 3 min

Congress highlights

Treatment-Resistant Schizophrenia (TRS): Treatment Response and Resistance in Psychosis (TRRIP) Consensus Guidelines – a benchmark for research and clinical translation

The Treatment Response and Resistance in Psychosis (TRRIP) Consensus Guidelines now allow...

Other conferences

Read time: Read time: 1 min

Read time: Read time: 1 min

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country